Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
CTV.WS
CTV.WS was delisted on the 12th of February, 2025.
1 hedge funds and large institutions have $625 invested in Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share in 2025 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 18 closing their positions.
95% less funds holding
Funds holding: 19 → 1 (-18)
100% less capital invested
Capital invested by funds: $686K → $625 (-$685K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 18
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PF
Phoenix Financial
Givatayim,
Israel
|
-$252K |
| 2 |
BFM
Boothbay Fund Management
New York
|
-$239K |
| 3 |
LP
LMR Partners
London,
United Kingdom
|
-$116K |
| 4 |
MC
Meteora Capital
Boca Raton,
Florida
|
-$13.9K |
| 5 |
IAM
Ion Asset Management
Herzliya,
Israel
|
-$13.7K |
CTV.WS Hedge Fund Activity: Q1 2025 in Review
1 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (CTV.WS) for Q1 2025, worth a combined $625 — down 100% from $686K a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of CTV.WS and 0 opened new positions — a net loss of 18 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was Phoenix Financial, exiting entirely with an estimated $252K sold.
- 1 institutional investor held Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (CTV.WS) as of Q1 2025, down from 19 in Q4 2024.
- Funds reported $625 of Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share stock for Q1 2025, down 100% quarter-over-quarter.
- 0 funds opened new Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share positions in Q1 2025 and 18 closed out, a net change of -18 holders.
- The largest Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share seller in Q1 2025 was Phoenix Financial, an estimated $252K sold.
Based on aggregated 13F filings for Q1 2025.